Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 528 | 53 | -142 | 2,513 | 633 |
| Depreciation Amortization | 322 | 217 | 112 | 284 | 213 |
| Accounts receivable | 1,304 | 2,319 | 2,235 | -2,185 | -859 |
| Other Working Capital | 588 | 615 | 1,578 | -1,969 | -778 |
| Other Operating Activity | -1,182 | -2,277 | -2,222 | 2,374 | 1,004 |
| Operating Cash Flow | $1,559 | $926 | $1,560 | $1,017 | $214 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -282 | -288 | -46 | -182 | -188 |
| Investing Cash Flow | $-282 | $-288 | $-46 | $-182 | $-188 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 250 | 231 |
| Debt Repayment | -648 | -914 | -895 | -54 | -16 |
| Common Stock Issued | 280 | 279 | 42 | 38 | 27 |
| Financing Cash Flow | $-368 | $-635 | $-853 | $234 | $242 |
| Beginning Cash Position | 2,136 | 2,136 | 2,136 | 1,068 | 1,068 |
| End Cash Position | 3,045 | 2,139 | 2,797 | 2,136 | 1,336 |
| Net Cash Flow | $909 | $3 | $661 | $1,068 | $268 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,559 | 926 | 1,560 | 1,017 | 214 |
| Capital Expenditure | -282 | -288 | -46 | -182 | -188 |
| Free Cash Flow | 1,277 | 638 | 1,514 | 835 | 26 |